ID   Vero-B4
AC   CVCL_1912
SY   VERO-B4; Vero B4; VeroB4
DR   CLO; CLO_0009528
DR   CLDB; cl4659
DR   CCLV; CCLV-RIE 0929
DR   CCLV; CCLV-RIE 1146
DR   DSMZ; ACC-33
DR   DSMZCellDive; ACC-33
DR   Wikidata; Q54993054
RX   PubMed=25531820;
RX   PubMed=34339474;
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Virology: Susceptible to infection by Middle East respiratory syndrome-related coronavirus (MERS-CoV) (PubMed=25531820).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: ~25 hours (DSMZ=ACC-33).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 20
//
RX   PubMed=25531820; DOI=10.3201/eid2101.141342; PMCID=PMC4285277;
RA   Meyer, Benjamin
RA   Garcia-Bocanegra, Ignacio
RA   Wernery, Ulrich
RA   Wernery, Renate
RA   Sieberg, Andrea
RA   Muller, Marcel Alexander
RA   Drexler, Jan Felix
RA   Drosten, Christian
RA   Eckerle, Isabella
RT   "Serologic assessment of possibility for MERS-CoV infection in
RT   equids.";
RL   Emerg. Infect. Dis. 21:181-182(2015).
//
RX   PubMed=34339474; DOI=10.1371/journal.pone.0255622; PMCID=PMC8328321;
RA   Pommerenke, Claudia
RA   Rand, Ulfert
RA   Uphoff, Cord C.
RA   Nagel, Stefan
RA   Zaborski, Margarete
RA   Hauer, Vivien
RA   Kaufmann, Maren
RA   Meyer, Corinna
RA   Denkmann, Sabine A.
RA   Riese, Peggy
RA   Eschke, Kathrin
RA   Kim, Yeonsu
RA   Safranko, Zeljka Macak
RA   Kurolt, Ivan-Christian
RA   Markotic, Alemka
RA   Cicin-Sain, Luka
RA   Steenpass, Laura
RT   "Identification of cell lines CL-14, CL-40 and CAL-51 as suitable
RT   models for SARS-CoV-2 infection studies.";
RL   PLoS ONE 16:e0255622.1-e0255622.15(2021).
//